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Abstract
With mounting data on its accuracy and prognostic value, cardiovascular magnetic resonance (CMR) is becoming an
increasingly important diagnostic tool with growing utility in clinical routine. Given its versatility and wide range of
quantitative parameters, however, agreement on specific standards for the interpretation and post-processing of CMR
studies is required to ensure consistent quality and reproducibility of CMR reports. This document addresses this need by
providing consensus recommendations developed by the Task Force for Post-Processing of the Society for Cardiovascular
Magnetic Resonance (SCMR). The aim of the Task Force is to recommend requirements and standards for image
interpretation and post-processing enabling qualitative and quantitative evaluation of CMR images. Furthermore, pitfalls
of CMR image analysis are discussed where appropriate. It is an update of the original recommendations published 2013.
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Preamble
Cardiovascular magnetic resonance (CMR) has evolved
into a gold standard non-invasive imaging tool in cardio-
vascular medicine, especially for visualizing and quanti-
fying cardiovascular anatomy, volumes, and function, as
well as for myocardial tissue characterization. CMR has
unique capabilities in the diagnostic workup of sus-
pected cardiovascular disease. It continues to expand its
utility in day-to-day clinical practice. Given its versatility
and wide range of quantitative parameters, agreement
on specific standards for the image interpretation and
post-processing of CMR studies is required to ensure
consistent quality and reproducibility of CMR reports.
This document addresses this need by updating the 2013
consensus recommendations developed by the Task Force
for Post-Processing of the Society for Cardiovascular Mag-
netic Resonance (SCMR) [1]. The aim of the document is
to recommend requirements and standards for image
interpretation and post-processing, enabling qualitative
and quantitative evaluation of CMR images. Furthermore,
pitfalls of CMR image analysis are discussed where appro-
priate. The Task Force is aware that for some of the rec-
ommendations the body of evidence is limited. Thus, this
document represents an expert consensus providing guid-
ance based on the best available evidence at present as
endorsed by the SCMR. As CMR continues to develop,
updated recommendations for image acquisition, inter-
pretation and post-processing will be provided by online
appendices when needed and updated Task Force papers.
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The recommendations are considered for the applica-
tion of CMR in clinical routine in adult patients. For
some applications, quantification is considered as
providing added information but is not mandatory (e.g.,
perfusion), whereas for others quantification is required
for all clinical reports (e.g., T2* assessment in iron over-
load). In general, the intention of this Task Force is to
describe the scenarios in which quantitative analysis
should be performed and how it is performed. Quantifi-
cation itself is a moving target as artificial intelligence
approaches to quantification are presently being insti-
tuted within CMR analysis software programs and will
impact techniques in this arena in the future. The rec-
ommendations respect societal recommendations for
structured reporting of cardiovascular imaging studies in
general (ACCF / ACR / AHA / ASE / ASNC / HRS /
NASCI / RSNA / SAIP / SCAI / SCCT / SCMR) [2] and
specifically for CMR studies (SCMR) [3]. The recom-
mendations do not supersede clinical judgment regard-
ing the contents of individual interpretation of imaging
studies. The Task Force made every effort to avoid con-
flicts of interest and, where present, to disclose potential
conflicts.
General recommendations
The recommendations listed in this section apply to the
acquisition and post-processing of all CMR data. CMR
studies should be performed for recommended indications.
Data acquisition and reporting should conform to the
recommendations of SCMR [3, 4]. Consistent methods of
acquisition and measurements are essential for serial evalu-
ation of changes over time. Standardized structured reports
with tables of measurements are helpful for reporting
follow-up examinations. Any analysis should be performed
using uncompressed or lossless compressed Digital Imaging
and Communications in Medicine (DICOM) source im-
ages. Factors like type of sequence, spatial resolution, con-
trast agent and kinetics may influence visual and
quantitative analysis and should be considered. Quantitative
values should only be provided based on adequate image
quality. Since there are no objective criteria for inadequate
images, this determination needs to rely on the experience
of the reporting physician. Readers should have adequate
training and clinical experience that includes normal data-
sets to avoid over-interpretation of normal variants. The
identity and responsibility of the reader should be appropri-
ately documented in the report. Furthermore, the reader of
clinical data is also responsible for the use of adequate
post-processing hardware and software. The general re-
quirements include:
1. Workstation and screen of adequate specification
and resolution (as per the specifications of the post-
processing software)
2. Post-processing software with regulatory approval
for use in patients, ideally providing the following
tools:
a) Full DICOM send/retrieve functionality,
network connection with local Picture
Archiving and Communication System (PACS)
or server solution with compliant patient
security properties
b) View all short-axis cines as movies in a single
display, zoom, pan and change contrast for
single images as well as image series
c) Perform endocardial and epicardial contour
tracings on cines
d) Correct for atrioventricular annular location
from the long-axis slice onto the most basal left
ventricular (LV) short-axis location in contour
tracings
e) Cross-referencing of structures for confirmation
of slice position and anatomy
f) Simultaneously view cine, late gadolinium
enhancement (LGE) and/or perfusion images
from the same location
g) Simultaneously view short- and long-axis images
of the same region
h) Simultaneously view images of the approximate
same location on the current and prior study for
serial studies
i) Perform quantitative signal intensity (SI) and
derived analyses
j) Perform standardized segmentation of the
myocardium according to the segment model of
the American Heart Association (AHA) [5]
k) Measure flow velocities and flow volumes
l) Manually correct or enter heart rate, blood
pressure, height, weight, body surface area
m) Calculate volumes in stacked or 3D datasets
with minimal user interaction, including and
excluding trabecular tissue and papillary
muscles from the LV volume [6]
n) Document important findings in screenshots for
the report
o) For evaluation of angiography the software
ideally provides the following tools:
i) 3D multiplanar and maximum intensity
projection (MIP) capabilities
ii) Volume rendering and surface shaded
reconstructions optional for reporting but
not mandatory for quantitative analysis
iii) Measurement of distances and areas in
3D-MR angiography (MRA) images
iv) MIP reconstruction based on non-
subtracted or subtracted 3D-MRA
datasets
v) Multiplanar reformatting (MPR)
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Left ventricular chamber assessment
Visual analysis
a) Before analyzing the details, review all cines in cine
mode, validate observations from one plane with
the others, and check for artifacts, especially in
patients with irregular heart rates.
b) Dynamic evaluation of global LV function:
Interpretation of both ventricular chambers, in
concert with extracardiac structures including
assessment for hemodynamic interaction between
the two chambers (e.g., shunts, evidence of
constrictive physiology).
c) Assessment of LV function from a global and
segmental perspective. Segmental wall motion is
based on segmental wall thickening during
systole. Wall motion is categorized as:
hyperkinetic, normokinetic, hypokinetic, akinetic,
dyskinetic.
d) In presence of segmental wall motion abnormalities,
use of standard LV segmentation nomenclature
corresponding to the supplying coronary artery
territories is recommended [3, 5, 7].
Quantitative analysis
a) General recommendations
i) In patients with severe arrhythmias, the end-
systolic volumes tend to be overestimated and
ejection fraction underestimated. In case of sig-
nificant artifacts this should be denoted in the
report.
ii) Calculated parameters: LV end-diastolic volume,
LV end-systolic volume, LV stroke volume, LV
ejection fraction, cardiac output, LV mass, and
body-surface area indexed values of all except
ejection fraction. The parameters quantified
may vary depending on the clinical need.
iii) Evaluation of the stack of short axis images with
computer-aided analysis packages.
iv) Contours of endocardial and epicardial borders
at end-diastole and end-systole (Fig. 1).
v) Epicardial borders should be drawn on the
middle of the chemical shift artifact line (when
present).
vi) The LV end-diastolic image should be chosen as
the image with the largest LV blood volume.
Fig. 1 Left ventricular (LV) chamber quantification. For LV chamber quantification, the endocardial (blue) and epicardial (yellow) contours are
delineated in diastole (left) and systole (right) in a stack of short axis slices that cover the whole left ventricle. a and b illustrate the approach with
inclusion of the papillary muscles as part of the LV volume. c and d show the approach with exclusion of the papillary muscles from the
LV volume
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For its identification, the full image stack should
be be evaluated and one phase has to be identi-
fied as end-diastole for all the short axis loca-
tions. In addition, closure of the mitral valve or
the phase immediately before opening of the
aortic valve may be used for orientation.
vii) The LV end-systolic image should be chosen as
the image with the smallest LV blood volume.
For its identification, the full image stack has to
be evaluated and one phase has to be identified
as end-systole for all the short axis locations.
viii)Deviations may occur and extra care should be
taken in the setting of LV dyssynchrony.
ix) Automatic contour delineation algorithms must
be checked for appropriateness by the reader.
b) LV volumes
i) Papillary muscles and trabecular tissue are
myocardial tissue and thus ideally should be
included with the myocardium as part of LV
mass. As there is still discussion on the exact
delineation of papillary muscles (e.g. versus
trabeculation) and not all evaluation tools allow
for their inclusion without manual drawing of
contours, they are often included in the blood
pool volume in clinical practice, which is
acceptable. Reference ranges that use the same
approach both on the acquisition and post-
processing side must be used. (Fig. 1) [8–10].
ii) Outflow tract: The LV outflow tract is included
as part of the LV blood volume. When aortic
valve cusps are identified on the basal slice(s)
the contour is drawn to include the outflow
tract to the level of the aortic valve cusps.
iii) Basal descent: As a result of systolic motion of
the mitral valve toward the apex (basal descent),
care must be taken with the one or two most
basal slices by using a standardized consistent
approach. A slice that contains LV blood volume
at end-diastole may include only left atrium (LA)
without LV blood volume at end-systole. The LA
can be identified by tracking wall thickening (if
there is thickening - then it is in the LV cavity)
and cavity (shrinking in systole, when in the cav-
ity). Alternatively, the basal slice may be defined
by at least 50% of the blood volume surrounded
by myocardium. Currently however, there is no
expert consensus on which method to use. Some
software packages automatically adjust for systolic
atrioventricular ring descent using cross-
referencing from long axis locations.
c) LV mass
i) Calculation: difference between the total
epicardial volume (sum of epicardial cross-
sectional areas multiplied by the sum of the slice
thickness and interslice gap) minus the total
endocardial volume (sum of endocardial cross-
sectional areas multiplied by the sum of the slice
thickness and interslice gap), which is then
multiplied by the specific density of myocardium
(1.05 g/ml).
ii) Papillary muscles: Papillary muscles and
trabecular tissue are myocardial tissue and thus
ideally should be included with the myocardium
as part of LV mass, and this is particularly
relevant in diseases with LV hypertrophy [6].
However, readers may decide to exclude
trabecular tissue and papillary muscles from the
myocardial mass. Reference ranges that use the
same approach must be used (Fig. 1) [8–10].
iii) Basal descent and apex: When the most basal
slice contains only a small crescent of basal
lateral myocardium and no discernable
ventricular blood pool, an epicardial contour for
the visible myocardium is included for LV mass
only. Similarly, when the most apical slice
contains only a circle of myocardium without
cavitary blood pool, an epicardial contour
without an endocardial contour should be
drawn for LV mass calculations.
d) Rapid quantitative analysis
i) A rapid quantitative analysis, known as the area-
length method, can be performed using biplanar
(e.g. 2- and 4-chamber views) or rotational mul-
tiple long axis views. In cases without expected
significant regional variation of wall motion, this
technique allows for faster evaluation and is not
limited by problems related to basal descent.
However, the 4-chamber view is strongly influ-
enced by breath-hold position. The accuracy is
not similar to short axis coverage, but allows a
fast analysis often more similar to transthoracic
echocardiography results. When the area-length
method is used, with either a single long-axis view
or a biplane approach, specific mention of the
analysis technique should be made in the report.
ii) Calculation [11–13]:
– Single long-axis equation: LV volume =
0.85 × (LV-area)2/ LV-length. This is typically
performed using a 4-chamber view with cal-
culations of LV volume obtained on both
end-diastolic and end-systolic phases. LV
area is the planimetered area of the LV cavity
from an endocardial contour with the base
drawn as a straight line through the medial
and lateral aspects of the mitral annulus. LV
length is the linear dimension from the mid-
point of the mitral annular line to the apical
tip of the endocardial contour.
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– Biplane equation: LV volume = 0.85 × (LV-area1
x LV-area2) / LV length. Here, both 4-chamber
(LV-area1) and 2-chamber [or vertical] (LV-
area2) long-axis views are used to calculate both
end-diastolic and end-systolic volumes, similar
to the single long-axis equation.
– Multi-plane long axis: A series of long-axis
views rotating around the central longitudinal
axis of the LV is used to calculate volumes.
Six views provide results that do not differ
from short-axis stacks [14].
e) Cavity diameter and LV wall thickness can be
obtained similar to echocardiography using two
CMR approaches [12, 15]:
i) Basal short-axis slice: immediately basal to the
tips of the papillary muscles.
ii) 3-chamber view: in the LV minor axis plane at
the mitral chordae level basal to the tips of the
papillary muscles.
iii) Both approaches have good reproducibility. The
3-chamber view is most comparable to data
obtained with echocardiography.
iv) For maximal LV wall thickness, the measurement
should be made perpendicular to the LV wall to
ensure accurate measurements. At the apex,
short-axis images are oblique to the axis of the
wall and will be inaccurate. In this location in par-
ticular, long-axis views should be used.
f) Research:
i) Real-time cine acquisitions become increasingly
available and might be beneficial in patients
with arrhythmia or limited breathholding
capacity. 3D cine acquisitions are also evolving
to accelerate examination time. Post-processing
of real-time images and 3D cine acquisitions is
still technically evolving. The Task Force
chooses to refrain from making a dedicated
statement at this time.
ii) Quantitative evaluation of LV myocardial
dynamics (e.g., strain, rotation, time-to-peak vel-
ocity) is feasible by several imaging techniques
(e.g., tagging, DENSE, SENC, tissue phase map-
ping, feature tracking) and requires specific post-
processing software. As research applications are
evolving and consensus evidence is being accu-
mulated, the Task Force chooses to refrain from
making a dedicated statement at this time.
Right ventricular (RV) chamber assessment
Visual analysis
a) Review all cines in cine mode, validate observations
from one plane with the others, and check for
artifacts and coverage of the right ventricle (RV).
b) Assessment of global and regional RV function
(septal wall, free wall), where appropriate. Wall
motion should be described as hyperkinetic,
normokinetic, hypokinetic, akinetic, or dyskinetic.
For qualitative regional analysis, wall motion in the
RV free wall (e.g., basal, mid, and apical portions),
outflow tract and inferior wall may be evaluated as
relevant to the specific clinical scenario and
diagnosis.
c) Assessment of LV and RV chambers for




i) Calculated parameters: RV end-diastolic volume,
RV end-systolic volume, RV ejection fraction, RV
stroke volume, cardiac output, and body-surface
area indexed values of all except ejection fraction.
Similar to the LV, the parameters quantified may
vary depending on the clinical need [16].
ii) The contiguous stack of short-axis images or
axial cine images is evaluated with computer-
aided analysis packages (Fig. 2) [17, 18]. Auto-
matically generated contours have to be care-
fully reviewed.
iii) An axial stack of cines covering the RV provides
the best identification of the tricuspid valve
plane. A short-axis stack of cines is best for de-
lineating the inferior wall.
iv) Endocardial borders are contoured at end-
diastole and end-systole (Fig. 2).
v) The RV end-diastolic image should be chosen as
the image with the largest RV blood volume.
For its identification, the full image stack has to
be evaluated and one phase has to be identified
as end-diastole for all locations.
vi) RV end-systolic image should be chosen as the
image with the smallest RV blood volume. For
its identification, the full image stack has to be
evaluated and one phase has to be identified as
end-systole for all slices.
vii) As for the LV, it may be necessary to review all
image slices in the stack to define end-systole.
viii)The pulmonary valve may be visualized, and
contours are included just up to, but not
superior to this level.
b) RV volumes
i) Total volumes are taken as the sum of volumes
from individual 2D slices, accounting for any
interslice gap and slice thickness. RV trabeculae
and papillary muscles are typically included in
RV volumes.
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c) RV mass is usually not quantified in routine assessment.
In selected patients, quantification of RV mass may be
considered (e.g., in pulmonary hypertension).
d) Confirmation of results
i) If no shunts or valvular regurgitation is
present, the RV and LV stroke volumes
should be nearly equal (small differences are
seen as a result of bronchial artery supply
and papillary muscle inclusions in the
measurements). Since the LV stroke volume
is more reliably determined than the RV
stroke volume, the LV data can be used to
validate RV data.
Post-processing of myocardial perfusion imaging
Visual analysis
a) Workflow:
i) Display perfusion and corresponding LGE
images side-by-side.
ii) Adjust window, contrast and brightness level for
an optimized contrast within the LV
myocardium (not the entire image). The aim of
image adjustment is to set a maximal window
width without “spilling” of the LV cavity signal
into the myocardium. Ensure that myocardium
before contrast arrival is nearly black and that
the window settings maximize the contrast
within the myocardium. Note that that the
correct level and window settings requires
review of both pre- and peak contrast images.
iii) Apply the same contrast, brightness and window
settings to all images of the dynamic series.
iv) Review series as cines and/or by scrolling
through individual images.
v) Check that there was an adequate
haemodynamic response to stress by reviewing
Fig. 2 Right ventricular (RV) chamber quantification. For RV volume quantification, the endocardial (red) contours are delineated in diastole (a)
and systole (b) in a stack of transaxial slices covering the whole RV (top). Alternatively, a stack of short axis slices can be used (c, d). Here, the
yellow contours indicate the RV in diastole (c) and systole (d); the RV is contoured following the LV analysis (in c and d, red / green contours
indicate endocardial / epicardial borders of the LV) and with reference to the LV
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the heart rate and blood pressure change
between stress and symptomatic response to
stress. Images may also be checked for ‘splenic
switch off’ during stress [19].
vi) The key diagnostic feature for identifying a
perfusion defect is the arrival and first passage
of the contrast bolus through the LV
myocardium.
vii) Visual analysis is based on a comparison
between regions to identify relative
hypoperfusion. Comparison should be made
between endocardial and epicardial regions,
between segments of the same slice and
between slices.
b) Stress images alone may permit the diagnosis of
inducible perfusion defects. When the diagnosis is
unclear based on stress images alone and rest
images are available, these two image series can be
compared. In general, an inducible perfusion defect
will be present on the stress, but not the rest
images. If perfusion defects are seen on both stress
and rest images, they may be artifacts or have other
causes such as myocardial scar. Note that artifacts
may be less pronounced or absent on rest
compared with stress images due to differences in
haemodynamics and contrast kinetics between
stress and rest.
c) Scar tissue may not necessarily cause a perfusion
defect, especially if rest perfusion is acquired after
stress. Scar should therefore always be identified
from LGE and not from perfusion images.
d) Criteria for an inducible perfusion defect (Fig. 3a):
i) Occurs first when contrast arrives in LV
myocardium.
ii) Persists beyond peak myocardial enhancement
and for several RR intervals.
iii) Is more than two pixels wide.
iv) Is usually most prominent in the subendocardial
portion of the myocardium.
v) Often manifests as a transmural gradient across
the wall thickness of the segment involved: most
dense in the endocardium and gradually
becoming less dense towards the epicardium.
vi) Over time, defect regresses from the
subepicardium towards the subendocardium.
vii) Is present at stress but not at rest.
viii)Conforms to the distribution territory of one or
more coronary arteries.
e) Interpret location and extent of inducible perfusion
defect(s) using AHA segment model [5].
i) Comment on transmurality of perfusion defect
[20].
ii) Indicate extent of perfusion defect relative to
scar on LGE.
f) Criteria for dark banding artifacts (Fig. 3b): A
common source of false-positive reports are suben-
docardial dark banding artifacts [21]. These artifacts
have the following characteristics:
– Are most prominent when contrast arrives in the
LV blood pool.
– Lead to a reduction in signal compared with
baseline myocardial signal whereas a true
perfusion defect does not show a decrease in
signal compared with baseline. These subtle
differences can be hard to appreciate visually. It
can therefore be helpful to draw a region of
interest (ROI) around the suspected artifact and
display its SI-time profile.
– Persist only transiently before the peak myocardial
contrast enhancement.
– Appear predominantly in the phase-encoding
direction.
Fig. 3 Perfusion imaging. a Perfusion defect in the inferior segments (yellow arrow). Note defect is predominantly subendocardial, affects the
perfusion territory of the right coronary artery and is more than one pixel wide. b Dark banding artifact (yellow arrow). Note defect is very dark,
occurs already before contrast reaches the myocardium, is seen in the phase encoding direction (right-left in this case), and is approximately one
pixel wide. c Positioning of endocardial (red) and epicardial (green) contours and a region-of-interest (ROI) in the LV blood pool (blue) for
semiquantitative or quantitative analysis of perfusion data
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– Are approximately one pixel wide.
Dark banding present at stress and at rest with
no corresponding scar on LGE images is also
indicative of an artifact [22]. Note however that
differences in heart rate and baseline contrast can
change the appearance and presence of dark
banding between stress and rest perfusion images.
Thus, absence of dark banding at rest with typical
dark banding at stress should not on its own be
considered diagnostic for an inducible perfusion
defect.
g) Pitfalls of visual analysis
i) Multi-vessel disease: Visual analysis is based on
relative signal differences within an imaged
section of the heart. Theoretically, the presence
of balanced multivessel disease can result in
most or all of the imaged section appearing
hypoperfused, which can lead to false-negative
readings and needs to be considered in relevant
clinical circumstances. In practice, however,
truly balanced ischaemia is rare and a perfusion
defect in one or more territories will be more
prominent. Even if all coronary territories are
affected, the severity of the observed defects typ-
ically is more pronounced around the geo-
graphic center(s) of the coronary territories. In
addition, a clear endocardial to epicardial signal
gradient is usually seen in multi-vessel disease
[23]. Quantitative analysis of the dynamic perfu-
sion data may be of further help to detect glo-
bally reduced myocardial perfusion reserve in
multi-vessel disease.
ii) Microvascular disease: Diseases that affect the
myocardial microvasculature (e.g., diabetes
mellitus, systemic hypertension) may lead to a
global subendocardial reduction in perfusion
[24–27]. This can lead to false-positive readings
relative to angiographic methods and needs to
be considered in relevant clinical circumstances.
Features suggesting microvascular disease are
the presence of concentric LV hypertrophy and
a concentric, often subendocardial perfusion de-
fect crossing coronary territories. Differentiation
from multi-vessel disease can be challenging.
iii) If vasodilation during stress data acquisition
was inadequate, visual analysis may lead to
false negative interpretation of the perfusion
study [28].
iv) The distance of the myocardium to the surface
coil affects signal intensity and may lead to
misinterpretation if not considered in the
analysis. These problems are less likely if
acquisition is corrected for coil sensitivity.
Quantitative analysis
a) A quantitative analysis of the SI change in
myocardial perfusion CMR studies can be
performed. Several methods have been described
for this purpose. In clinical practice, these are rarely
required, but they may supplement visual analysis
for example in suspected multi-vessel disease or
suspected inadequate response to vasodilator stress.
Fully automated methods for quantitative perfusion
analysis are becoming available and may soon be-
come more widely used. Quantitative analysis is also
frequently used in research studies.
b) Requirements:
i) Validation and definition of a normal range with
the specific pulse sequence and contrast regime
used for data acquisition. If only a comparison
between regions of the same study is made,
establishing a normal range is less relevant.
ii) A temporal resolution of one RR interval is
recommended.
iii) Consideration of potential saturation effects
(higher contrast agent doses are more likely to
lead to saturation effects).
c) Semi-quantitative analysis:
i) Analysis methods that describe characteristics of
the SI profile of myocardial perfusion CMR
studies without estimating myocardial blood
flow are typically referred to as “semi-
quantitative analysis methods”.
ii) Workflow:
– Select an image from the dynamic series with
good contrast between all cardiac
compartments (some post-processing tools
generate an average image of the series).
– Outline LV endocardial and epicardial
contours on this image (manual or
automated) (Fig. 3c).
– Propagate contours to all other dynamic
images.
– Correct contour position for in-plane motion
(some analysis packages register images prior
to contours being outlined).
– Depending on the type of analysis to be
performed, place a separate ROI in the LV
blood pool. Preferably, the basal slice is used.
Exclude papillary muscles and flow artifacts
from the ROI.
– Select a reference point in the LV
myocardium for segmentation (usually one of
the RV insertion points) [5].
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– Segment LV myocardium according to AHA
classification [5]
– Generate SI / time profiles for myocardial
segments +/− LV blood pool.
– Consider generating division into endocardial
and epicardial layers and repeat analysis [20].
iii) Frequently used semi-quantitative analysis
methods (see [29] for detailed review):
– Maximal upslope of the myocardial SI profile,
may be normalized to LV upslope [30].
– Time to peak SI of the myocardial SI profile
[31, 32].
– Ratio of stress/rest values for the above
(often referred to as “myocardial perfusion
reserve index”) [33, 34].
– The upslope integral (area under the signal
intensity-time curve) [35].
iv) Limitations of semi-quantitative analysis
methods:
– SI may vary according to distance from coil.
This can be partially corrected by using a
pre-contrast proton density image or other
coil sensitivity correction tools.
– No absolute measurement of myocardial
blood flow given.
d) Quantitative analysis
i) Analysis methods that process the SI profile of
myocardial perfusion CMR studies to derive
estimates of myocardial blood flow are typically
referred to as “quantitative analysis methods”
[29, 36, 37].
ii) Requirements:
– It is a prerequisite for reliable quantification
that data acquisition used an appropriate
pulse sequence and contrast regime.
– The requirements for the acquisition method
depend on the analysis method. Currently,
this typically requires at least a proton
density image, the generation of an input
function which is not saturated by using dual
bolus [38] or dual contrast [39].
– Motion correction to correct for respiratory
motion is preferable.
iii) Workflow:
– Manual analysis methods require contour
placement as described above for semi-
quantitative analysis. Dynamic SI data are
then typically exported to off-line worksta-
tions for further processing.
– Fully automated methods are becoming
available, which generate pixel-wise maps of
myocardial perfusion without user input.
iv) Several analysis methods have been described,
including:
– Model-based methods [40, 41].
– Model-independent methods [42, 43].
Post-processing of late gadolinium enhancement
(LGE) of the left ventricle
Visual assessment
a) For most clinical indications, visual assessment of
LGE images is sufficient.
b) Workflow:
i) Modify image window and level so that:
– Noise is still detectable (nulled myocardium
should not be a single image intensity).
– LGE regions are not saturated (LGE regions
should not be a single image intensity).
ii) Note, on magnitude (not phase-sensitive
inversion recovery [PSIR]) images, if normal
myocardium has a faint “etched” appearance
(darkest at the border with slightly higher
image intensity centrally), this signifies an
inversion time that was set too short and will
lead to underestimation of the true extent of
LGE (Fig. 4). In general, an inversion time
that is slightly too long is preferred to one
that is slightly too short [44].
c) Criteria for presence of LGE.
i) High SI area that is visibly brighter than
“nulled” myocardium.
ii) Verify regions with LGE in at least one other
orthogonal plane and/or in the same plane
obtain a second image after changing the
direction of readout.
d) Assess pattern of LGE
i) Coronary artery disease (CAD) type: Should
involve the subendocardium and be consistent
with a coronary artery perfusion territory.
ii) Non-CAD-type: Usually spares the
subendocardium and is limited to the mid-wall
or epicardium, although non-CAD-type should
be considered if subendocardial involvement is
global [45].
e) Interpret location and extent using AHA 17-segment
model [5] [20].
i) Comparison of LGE images should be made
with cine and perfusion images (if the latter are
obtained) to correctly categorize ischemia and
viability [46].
ii) Estimate average transmural extent of LGE
within each segment (0%, 1–25%, 26–50%,
51–75%, 76–100%) [44].
iii) In patients with acute myocardial infarction,
include subendocardial and mid-myocardial
hypoenhanced no-reflow zones as part of
infarct size.
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f) Pitfalls
i) Bright ghosting artifacts can result from poor
electrocardiogram (ECG) gating, poor breath-
holding, and long T1 species in the imaging
plane (e.g., cerebrospinal fluid, pleural effusion,
gastric fluid, etc.) [47]
ii) On non-PSIR images, tissue with long T1
(regions below the zero-crossing) may appear
enhanced [44, 48].
iii) Occasionally, it can be difficult to distinguish no
reflow zones or mural thrombus from viable
myocardium. Imaging using a long-inversion time
[49], using PSIR, or performing post-contrast cine
imaging may be helpful in this regard.
iv) In case of reduced contrast, the interpretation of
additional sequences may be necessary (see
below section “Dark-blood/grey blood LGE”).
v) In PSIR images manual windowing and
quantification algorithms may behave differently
when compared with magnitude images.
Quantitative analysis
a) Quantitative analysis is primarily performed to
measure LGE extent and/or grey-zone extent for re-
search purposes. Subjective visual assessment is still
a prerequisite to identify poor nulling, artifacts, no-
reflow zones, etc., and to draw endocardial and epi-
cardial borders.
b) Multiple different methods of delineating LGE extent
are described in the literature including the following:
manual planimetry, the n-SD technique, and the full
width half maximum (FWHM) technique. As the re-
search applications are evolving and consensus evi-
dence is being accumulated, the Task Force chooses
to refrain from making a dedicated statement at this
time regarding the optimal method for quantitative
assessment [50–55].
Research tools / quantitative analysis
a) Quantification of LGE extent:
i) Manual planimetry:
– Outline endocardial and epicardial borders.
– Manual planimetry of LGE regions in each slice.
– Summation of LGE areas.
– Multiplication of total LGE area with slice
thickness plus interslice gap as well as
specific gravity of myocardium provides the
approximate LGE mass, which can be used
to calculate the ratio of LGE to total
myocardial mass.
– Considered subjective.
– Adjustment for regions with intermediate
signal intensities (grey zones) caused by
partial volume can improve reproducibility of
measurements [54].
ii) The n-SD technique:
– Manual outlining of endocardial and
epicardial borders for the myocardial ROI.
– Manual selection of a normal “remote” (dark)
region ROI within the myocardium to define
the reference SI (mean and standard
deviation, SD). This subjective approach can
affect measurements.
– It is susceptible to spatial variations in
surface coil sensitivity.
– Selection of a threshold between normal
myocardium and LGE. The relative SNR of
scar tissue versus normal myocardium can
Fig. 4 Late gadolinium enhancement (LGE) imaging. Role of inversion time in LGE imaging: On the left panel which is a magnitude (non-PSIR)
LGE image, normal myocardium has a faint “etched” appearance (darkest at the border with higher signal intensity centrally) signifying an
inversion time that was set too short and which will lead to underestimation of LGE. On the right panel, the image was repeated with a longer
inversion time and demonstrates a larger LGE zone in the inferior wall. For non-PSIR magnitude imaging, always use the longest inversion time
possible that still nulls normal myocardium
Schulz-Menger et al. Journal of Cardiovascular Magnetic Resonance           (2020) 22:19 Page 10 of 22
vary dependent on contrast agent type, dose
and time after injection, field strength, type
of sequence and other variables including the
underlying injury itself. As such, there is no
cutoff value which works for all situations
and usually manual tracing is performed as
the standard of truth. But (semi-) automated
thresholding may improve reproducibility
after adequate standardization. As a starting
point for semiautomatic thresholding we
recommend 5-SD for infarction. There is
currently not enough evidence to provide a
cut-off for non-ischemic LGE.
– The presence of LGE within the myocardium
is then determined automatically.
– Requires manual corrections to include no-
reflow zones and to exclude artifacts and LV
blood pool (errors in the endocardial
contour).
iii) FWHM technique:
– Manual outlining of endocardial and
epicardial borders for the myocardial ROI.
– Uses the full width of the myocardial ROI SI
histogram at half the maximal signal within
the scar as the threshold between normal
myocardium and LGE.
– Visual determination whether LGE is present
or not, and, if LGE is present, manual
selection of a ROI that includes the region of
“maximum” signal. This subjective selection
can affect measurements.
– Is also susceptible to spatial variations in
surface coil sensitivity, albeit perhaps less so
than the n-SD technique [51].
– Considered more reproducible than the n-SD
technique [53].
– Since the technique assumes a bright LGE
core, it may be less accurate than the n-SD
technique if LGE is patchy or grey [56].
– Requires manual corrections to include no-
reflow zones and to exclude artifacts and LV
blood pool (errors in the endocardial
contour).
b) Peri-infarct zone:
– Multiple methods for quantifying the extent of the
peri-infarct or grey zones are reported [57, 58].
– The Task Force does not endorse any specific
evaluation technique due to the strong impact of
partial volume effects.
c) Dark-blood/grey blood LGE
– Multiple techniques are described in the
literature but one that is “flow-independent”,
(i.e., does not rely on blood flow to suppress
blood-pool signal) is preferable [59–61].
– As the research application(s) are evolving and
consensus evidence is being accumulated, the
writing group chooses to refrain from making a
dedicated statement at this time regarding the
optimal method for quantitative assessment of
dark-blood/grey blood LGE images.
d) LGE in other chambers than LV
There is increasing evidence about LGE imaging of the
RV, which is usually captured with standard LGE proto-
cols imaging the LV. Imaging the thin LA wall is difficult
and requires specialized sequences. As the applications
are evolving and consensus evidence is being accumu-
lated, the writing group chooses to refrain from mak-
ing a dedicated statement at this time regarding the
post-processing assessment of LGE in chambers other
than the LV.
Post-processing of T1 mapping
Background
In 2013, the “T1 Mapping Development Group” published
a consensus statement that proposed suitable terminology
and specific recommendations for site preparation, scan
types, scan planning and acquisition, quality control,
visualization and analysis, and technical directions [62].
Building on this initiative, the Consensus Group on
Cardiac MR Mapping has formed itself and published in
2017 “Clinical recommendations for CMR mapping of T1,
T2, T2* and extracellular volume: A consensus statement
by the Society for Cardiovascular Magnetic Resonance
(SCMR) endorsed by the European Association for
Cardiovascular Imaging (EACVI)” [63]. The following rec-
ommendations refer to these consensus statements. For
more details regarding when and how to use T1 mapping,
refer to this original consensus statement as well as to the
SCMR protocol recommendations (Fig. 5).
Visual analysis
a) The visual analysis of the series of differently T1-
weighted source images should aim to detect and
verify diagnostic image quality.
b) The visual analysis of the final T1 map should aim
to detect artifacts and verify diagnostic image
quality. Automatically generated quality control
maps (e.g., T1*) may be used to exclude
misregistration or significant artifacts.
c) Maps may be displayed in color if the pertinent
look-up tables are set according to site-specific
ranges of normal, or in gray scale in combination
with appropriate image processing, to highlight
areas of abnormality.
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Quantitative analysis
a) For global assessment and diffuse disease, a single
ROI should be drawn conservatively in the septum
on mid-cavity short-axis maps to reduce the impact
of susceptibility artifacts from adjacent tissues.
b) In case of artifacts or inconclusive results obtained
from mid-cavity ROIs, basal ROIs can be used for
validation.
c) For focal disease, additional ROIs might be drawn in
areas of abnormal appearance on visual inspection. A
very small ROI (< 20 pixels) should be avoided.
d) The position and size of automatically generated
ROIs should be validated.
e) Drawing ROIs on greyscale images rather than
color maps may reduce bias.
f) For assessing diffuse disease, focal fibrosis as
assessed by LGE imaging should be excluded from
the ROI.
g) There is currently no specific recommended /
preferred analysis software package. The image
reader should be trained with the local standards
and with the analysis software package of choice
and be familiar with the appearance of artifacts.
h) The sensitivity of mapping techniques to
confounders such as heart rate and magnetic field
inhomogeneities should be considered during
interpretation.
i) Extracellular volume (ECV) estimation requires T1
mapping acquisitions before contrast agent
administration (native T1) and after contrast agent
administration (typically > 10 min post-contrast to
approach steady-state conditions). The proposed
post-processing steps should be applied equally to
both maps.
j) For calculating ECV, a ROI in the center of the
blood pool in the native and in the post-contrast T1
map should be drawn excluding papillary muscles
and trabeculae.
k) For calculating ECV, hematocrit of the same day
should be available. If this is not available,
hematocrit may be estimated from native values of
blood pool T1 (“synthetic ECV”) [65].












  100−hematocritð Þ
m) Inline ECV maps can be a useful alternative to manual
ECV calculations. The raw images should be checked
to verify a diagnostic image quality and processing.
n) For clinical reports, the type of pulse sequence,
reference range, and type/dose of gadolinium
contrast agent (if applied) should be quoted.
o) Mapping results should include the numerical
absolute value, the Z-score (number of standard de-
viations by which the result differs from the local
normal mean; if available), and the normal range of
the CMR system.
p) Local results should be benchmarked against
published reported ranges, but a local reference
range should be primarily used.
q) Reference ranges should be generated from data
sets that were acquired, processed, and analyzed in
the same way as the intended application, with the
upper and lower range of normal defined by the
mean ± 2 SD of the normal data, respectively.
r) Parameter values should only be compared to other
parameter values if they are obtained under similar
conditions. In other words, the acquisition scheme,
field strength, contrast agent and processing
approach should be the same, and the results
should be reported along with corresponding
reference ranges for the given methodology.
Fig. 5 Native T1 map in a patient with acute myocarditis illustrating
T1 elevation in the subepicardial lateral LV wall (modified from [64])
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Post-processing of T2-weighted imaging
Visual analysis
a) The visual analysis of T2-weighted images aims for
detecting or excluding regions with significant SI in-
crease, as a marker for an increased free water con-
tent (edema).
b) Qualitative, visual analysis of myocardial SI may be
sufficient for diseases with significant regional
injury to the myocardium, such as acute ischemic
injury/infarction, acute myocarditis (Fig. 6), stress-
induced (Takotsubo) cardiomyopathy, and
sarcoidosis.
c) Workflow:
i) Identify and display appropriate image(s).
ii) Modify image contrast and brightness in the
myocardial tissue to minimize SI in the most
normal appearing myocardium (noise should
still be detectable there) and to maximize the
maximal SI displayed in the myocardium area
without allowing for “over-shining”, i.e.,
displaying non-white pixels as white.
iii) Check for artifacts (typically SI changes crossing
anatomical structures).
d) Criteria for edema:
i) Clearly detectable high SI area respecting
anatomical borders.
ii) Follows an expected regional distribution
pattern (transmural, subendocardial,
subepicardial, focal).
iii) Verifiable in two perpendicular views.
e) High SI areas suggestive of myocardial edema
should be compared to
i) regional function.
ii) other tissue pathology such as scar/fibrosis and
infiltration.
f) Pitfalls of visual analysis:
i) Surface coil reception field inhomogeneity: The
uneven distribution of the sensitivity of the
receiving surface coil may lead to falsely low SI in
segments distant to the coil or falsely high SI in
segments close to the coil surface, especially in
dark-blood triple-inversion recovery spin echo
(STIR, TIRM) images. If no efficient SI correction
algorithm for balancing the signal intensity across
the reception field is available, the body coil, albeit
with a lower signal-to-noise ratio, provides a
more homogeneous signal reception.
ii) Low SI artifacts: Arrhythmia or through-plane mo-
tion of myocardium may cause artifacts, making
areas appear with falsely low SI, especially in dark-
blood triple-inversion recovery spin echo images.
iii) High SI artifacts: In dark-blood triple-inversion
recovery spin echo images, slow flowing blood
may lead to insufficient flow suppression and
results in high SI of blood, typically along the
subendocardial border. This can be confused
with myocardial edema.
Semi-quantitative analysis
a) Because low SI artifacts can lead to SI distribution
patterns that may mimic extensive myocardial
edema, a mere visual analysis may lead to incorrect
results. SI quantification with reference regions is
much less sensitive to these errors and therefore is
recommended.
b) Requirements:
i) Tested normal values for SI values or ratios.
c) Workflow
i) Global SI analysis:
– Outline LV endocardial and epicardial
contours.
– For the T2 SI ratio, draw the contour for a
ROI in a large area of the skeletal muscle
closest to the heart and to the center of the
reception field of the coil (for short axis views
preferably in the M. serratus anterior [66].
ii) Regional SI analysis:
– Draw the contour for a ROI in the affected
area and divide the SI by that of the skeletal
muscle.
iii) While a cut-off of 1.9 can be used for dark
blood triple-inversion recovery spin echo [67], a
locally established value is recommended,
Fig. 6 T2-weighted image (short-tau inversion recovery, STIR) in a
midventricular short axis view with increased SI in the inferolateral
and lateral segments in acute myocarditis
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because SI and ratio values may vary between
sequence settings (especially echo time (TE))
and CMR scanner models. For these images, a
color-coded map, based on the parametric cal-
culation and display of myocardial pixels with a
SI ratio of 2 or higher, can also be used.
Post-processing of T2 mapping
Background
The Consensus Group on Cardiac MR Mapping published
in 2017 “Clinical recommendations for CMR mapping of
T1, T2, T2* and extracellular volume: A consensus state-
ment by the Society for Cardiovascular Magnetic Reson-
ance (SCMR) endorsed by the European Association for
Cardiovascular Imaging (EACVI)” [63]. The following
recommendations refer to this consensus statement. For
more details regarding when and how to use T2 mapping,
refer to this original consensus statement as well as to the
SCMR protocol recommendations.
Visual analysis
a) The visual analysis of the series of differently T2-
weighted source images should aim for detecting
and excluding artifacts and significant motion.
b) The visual analysis of the final T2 map should aim
for detecting and excluding artifacts.
c) Maps may be displayed in color if the color look up
tables are set according to site-specific ranges of
normal, or in gray scale in combination with appro-
priate image processing, to highlight areas of
abnormality.
Quantitative analysis
a) For global assessment and diffuse disease, a single
ROI should be drawn conservatively in the septum
on mid-cavity short-axis maps to reduce the impact
of susceptibility artifacts from adjacent tissues.
b) In case of artifacts or non-conclusive results on mid-
cavity ROIs, basal ROIs can be used for validation.
c) For focal disease, additional ROIs might be drawn
in areas of abnormal appearance on visual
inspection. Very small ROIs (< 20 pixels) should be
avoided.
d) ROIs should be checked if generated automatically.
e) Drawing ROIs on greyscale instead of color maps
may avoid bias.
f) Depending on the goal of the analysis, focal fibrosis
as assessed by LGE imaging may be excluded from
the ROI.
g) There is currently no specific preferred analysis
software package. The image reader should be
trained with the local standards and with the
analysis software package of choice and be aware of
and familiar with the appearance of artifacts.
h) Sensitivity of mapping techniques to confounders
such as heart rate and magnetic field
inhomogeneities should be considered during
interpretation.
i) Mapping results should include the numerical
absolute value, the Z-score (number of standard de-
viations by which the result differs from the local
normal mean), and the normal reference range.
j) Parameter values should only be compared to other
parameter values if they are obtained under similar
conditions. In other words, the acquisition scheme,
field strength and processing approach should be
the same, and the results should be reported along
with corresponding reference ranges for the given
methodology.
Post-processing of T2* imaging
Visual analysis
T2* imaging always requires a quantitative analysis. Vis-
ual analysis is used to ensure adequate image quality,
which is the most important factor for the accuracy of
data analysis.
Quantitative analysis
a) Evaluation of T2* always requires a quantitative
analysis using software with regulatory approval for
T2* evaluation in patients.
b) Full thickness ROI located in the ventricular
septum
i) Septal ROI is drawn on mid-LV short-axis
image.
ii) Take care to avoid blood pool and proximal
blood vessels.
iii) A septal ROI avoids susceptibility artifact from
tissue interfaces.
c) Mean myocardial SI from the ROI is plotted against
TE (Fig. 7)
i) SI falls with increasing TE.
ii) Curve fitting should apply a validated algorithm.
iii) The time for the decay of SI falls (shorter T2*)
with increasing iron burden.
iv) In heavily iron overloaded patients, SI for higher
TEs may fall below background noise causing
the curve to plateau and underestimating T2*.
v) This can be compensated for by:
– Truncating the curve by removing later echo
times (Fig. 7e) [68, 69].
– This issue is not significant when using the
double inversion recovery (black blood)
sequence [70].
d) Cut-off values at 1.5 Tesla:
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i) Normal cardiac T2* is 40 ms [71]
ii) T2* < 20 ms indicates cardiac iron overload [72]
iii) T2* < 10 ms indicates increased risk of
development of heart failure [73]
e) CMR assessment of T2* at 3 T for assessment of
iron overload cardiomyopathy cannot be
recommended at this time. T2* shortens with
increasing field strength making assessment of
severe iron overload more problematic, and there is
a lack of clinical verification.
Flow image interpretation and post-processing
Background
CMR flow imaging provides information about blood flow
velocities and volumes, and enables the visualization of
blood flow. Flow assessment in a 2D slice is in widespread
use. Recently, temporally resolved flow evaluation in a 3D
volume (4D flow) has evolved enormously. It is currently
predominantly used for evaluating congenital heart dis-
ease. For further details regarding application, acquisition
and postprocessing of 4D flow also refer to the corre-
sponding consensus document [74].
Visual analysis
a) Appropriately aligned acquisitions of cines and
stacks of cines can give valuable information on
flow in relation to adjacent structures, notably on
the directions, time courses and approximate
dimensions of jets resulting from valve
regurgitation, stenoses or shunts. Such information
can be important in assessing the credibility of
measurements of flow, which may be subject to
several possible sources of error. Gradient echo
cines differ somewhat from balanced steady state
free precession (bSSFP) in terms of degrees of signal
augmentation or reduction attributable to flow
effects. Of note, bSSFP can provide clear delineation
between the relatively bright signal from voxels
aligned within the coherent core of a jet, and low
signal from the shear layer that bounds such a jet
core. In- or through-plane phase contrast flow vel-
ocity acquisitions can also provide visual informa-
tion on the directions, dimensions and time courses
of flow; it can also image morphology, which can
yield a clue to the etiology of an abnormal jet [75,
76]. It is also often used in congenital heart disease.
Color flow mapping in post-processing software
may be useful in determining directionality of the
jet or morphology.
b) Pitfalls:
i) Flow appearances on both cine and phase
encoded acquisitions are highly dependent on
image location and orientation, especially in the
case of jet flow.
ii) Check for the appropriate velocity encoding. If
the range of velocity encoding (VENC) is set too
high, visualization of the jet may not be obtained
and may be inaccurate as well as having poorer
SNR. If it is set too low, a mosaic pattern on the
images will be visualized [77].
iii) If slice thickness is too large on in- or through-
plane velocity mapping, the higher velocities will
be “averaged out” with the lower velocities and
stationary tissue; jets and flow may not be visu-
alized correctly.
iv) If the annulus of valves is very dynamic or the
imaging plane is not set correctly, the valve
morphology may not be visualized.
v) If imaging in the presence of metal containing
devices, signal loss may be present as artifact
and interpretation must proceed with caution.
vi) Check for appropriate spatial and temporal
resolution. For spatial resolution, 8 to 16 pixels
should fill the vessel to obtain accurate results
on through-plane velocity mapping. For tem-
poral resolution, there should be at least 11–16
frames per cardiac cycle [78].
Quantitative analysis
a) Workflow:
i) Through-plane measurements may be
supplemented by in-plane measures if needed.
ii) Review phase and magnitude images side by
side. Window the magnitude and phase images
to the appropriate brightness and contrast so
that the borders of the ROI are sharp.
iii) Examine the images to ensure the quality is
sufficient and that the VENC was not exceeded, or
there is little contrast (i.e., the VENC was too high).
iv) Trace the borders of the vessel of interest on
each phase and magnitude image so that only
the cavity of the vessel is included (Fig. 8); make
sure the noise outside the vessel is not included.
Check that this is performed correctly on the
magnitude images always keeping in mind that
it is the phase images that contain the encoded
information.
v) Baseline-correction may be considered. As the
utility and exact methods are not yet
established, the writing group chooses to refrain
from making a dedicated statement at this time
regarding its use.
vi) Directly calculated parameters include
antegrade and retrograde volume, flow rate,
peak and mean velocity.
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vii) Derived parameters include:
– Net volume [ml| = antegrade volume -
retrograde volume
– Regurgitant fraction [%] = (retrograde volume
/ antegrade volume) * 100.
– Cardiac output (liters/min = (net volume [ml]
x heart rate [beats/minute])/1000) and
cardiac index (cardiac output/body surface
area) when integrating heart rate and body
surface area (BSA)
– Regional flow to both lungs by measuring
cardiac output in each branch pulmonary
artery (e.g., percentage of flow to the right
lung = (right pulmonary artery flow / right
pulmonary artery flow + left pulmonary
artery flow) Å~ 100).
– Regurgitant volumes of the atrioventricular
valves may be obtained by either of 2
methods: A) direct measurement of diastolic
flow across the valve and subtraction of
systolic forward flow across the associated
semilunar valve or B) measurement of
ventricular stroke volume using cine CMR
and subtraction of forward flow across the
associated semilunar valve.
– Quantitative aortic regurgitant volume may
be inaccurate in the presence of a large,
dilated aorta. An alternative is to subtract net
Fig. 7 T2* imaging to assess myocardial iron overload. a T2* scan of a normal heart showing slow signal loss with increasing TE. b Decay curve
for normal heart. T2* = 33.3 ms. c Heavily iron overloaded heart. Note there is substantial signal loss at TE = 9.09. d Decay curve for heavily iron
overloaded heart showing rapid signal loss with increasing TE. The curve plateaus as myocardial SI falls below background noise. e Values for
higher TEs are removed (truncation method) resulting in a better curve fit and a lower T2* value
Schulz-Menger et al. Journal of Cardiovascular Magnetic Resonance           (2020) 22:19 Page 16 of 22
pulmonary artery flow or the sum of caval
return from the forward flow across the aortic
valve in the absence of significant aortic to
pulmonary collateral flow (noting that this will
be a slight overestimate as bronchial flow is ~
5% if total aortic output) [79].
– Estimation of cardiac shunts is feasible by
calculating Qp/Qs based on the stroke
volume obtained by flow measurements in
the pulmonary artery and at the aortic
sinutubular junction. Shunts can also be
quantified by direct measurement of the flow
through the shunt.
b) Pitfalls:
i) On the phase images, the area of flow may be
slightly larger than the area of the magnitude
images. Care has to be taken when evaluating
the magnitude images – the size of the ROI has
to be adapted.
ii) If the VENC is exceeded, some software
packages allow for adjusting the “dynamic
range” of the velocity scale so that the VENC is
not exceeded. For example, if the peak velocity
in the aorta is 175 cm/s and the VENC was set
at 150 cm/s, the dynamic range is between −
150 cm/s and + 150 cm/s (i.e., 300 cm/s). This
may be moved to − 100 cm/s and + 200 cm/s to
account for this accelerated velocity. This will
be demonstrated on the graph of the velocity
where the phase in which the VENC is
exceeded does not “alias” (appears to go the
wrong way) after correction.
iii) In general, the area that exceeds the VENC in
the ROI is in the center of the vessel and not at
the edges; if it is at the edges, it is usually (but
not always) outside the vessel.
iv) If imaging in the presence of devices, signal loss
may be present as artifact and interpretation
must proceed with caution [80].
v) When measuring peak velocity, some software
packages will determine the peak velocity in one
pixel in the ROI whereas others may take the
peak velocity of the average of a few adjacent
pixels in the ROI. By reporting the peak velocity
in a single pixel, noise may make this
measurement inaccurate. By reporting this as an
average of a few adjacent pixels, noise is less of
an issue, however, the true peak velocity may be
Fig. 8 Quantification of blood flow. (top) Contours were drawn delineating the aortic lumen at the sinotubular level during all 20 phases of the
cardiac cycle to assess aortic flow. (bottom) Flow curves from measurements in the ascending aorta and in the pulmonary artery in a patient with
ventricular septal defect showing a left-to-right shunt
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higher than the reported value. These factors
must be kept in mind and interpretation may
need to be adapted to the measurement
technique used.
vi) When attempting to measure peak velocity
using through-plane velocity mapping along a
vessel, interpretation should be tempered by
the notion that this parameter may be an
underestimate as the true peak velocity lies
somewhere along the vena contracta; the
through-plane velocity map may not have
been obtained at the level of the true peak
velocity. If the vena contracta is itself narrow
or ill defined, jet velocity mapping is unlikely
to be possible.
vii) Peak velocity is only minimally affected by
small background phase offsets, while volume
measurements can be dramatically affected by
even a small background phase offset due to
the cumulative aspect of integration overspace
(within the ROI) and time (over the cardiac
cycle). Dilatation of a vessel tends to increase
error of this type [81].
viii)Orientation of the image plane
perpendicular to flow direction can have a
significant impact on peak velocity
measurement, while not significantly
affecting volume flow [78].
ix) Internal consistency may be used to partially
assess the accuracy of measurement (e.g., the
sum of the flows in the branch pulmonary
arteries should sum to the flow in the main
pulmonary artery, and comparing the stroke
volume obtained by flow measurement with
the stroke volume obtained by volumetry of
cine images).
Research tools
a) Real time velocity mapping: The utility and post-
processing algorithm best applied to this approach
is the subject of ongoing research.
Post-processing of angiography of thoracic aorta,
pulmonary arteries and veins
Visual analysis
a) MIP for first review of 3D data and for
demonstration purposes (Fig. 9). Volume rendered
(VR) techniques may be used for demonstration
purposes, but not for quantitative analysis.
b) Aorta [82, 83]:
i) Wall thickness: Review bSSFP or turbo spin
echo images. Avoid measurement in areas with
artifacts that may distort anatomy, such as
chemical shift artifacts.
ii) Wall irregularities: Review 3D-MRA source im-
ages and bSSFP or turbo spin echo.
c) Pulmonary arteries [84]:
i) Multiplanar double oblique and targeted MIP
reconstructions for assessment of wall adherent
thrombi, emboli, wall irregularities and abrupt
diameter changes.
d) Pulmonary veins [85]:
i) Assess for atypical insertion, small accessory
veins and ostial stenoses.
e) Coronary arteries:
i) Coronary MRA (either contrast-enhanced or
non-contrast MRA using 3D whole heart
bSSFP) can play a role in assessment of con-
genital anomalies [86], but not usually in the
context of ischemic heart disease. The origins,
branching patterns, and course of coronary
Fig. 9 Magnetic resonance angiography. Stanford A aortic dissection after surgical repair with graft of ascending aorta. Panel a shows a source
image of breath-held 3D gradient recalled echo sequence after contrast injection. Multiplanar reformats in axial orientation (b) at the level of the
pulmonary trunk (PT) show a normally perfused ascending aorta graft (aAo) and persistent dissection in descending aorta with true (*) and false
(**) lumina. Double oblique reformat (c) shows narrowing at the origin of the left common carotid artery (arrow) and dissection membrane
propagating into the left subclavian artery (arrowhead) with perfusion of both lumina
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arteries is best assessed on source images,
MPR or targeted MIP reconstructions.
Quantitative analysis
a) Aorta:
i) Diameters of the aorta are measured on double
oblique MPR of source images perpendicular to
the vessel centerline at standardized levels
(Fig. 10) [87]. In oval shaped vessels the longest
diameter and its perpendicular diameter shall be
reported. Both, inner (lumen) or outer (external
vessel wall) diameter may be measured. This
should be included in the report, as well as the
type of angiography (with or without contrast-
enhancement). Measurement of outer contour is
recommended in dilation such as in aneurysms,
while the inner contour is recommended in the
setting of stenosis, such as in coarctation.
ii) In the presence of wall thickening (e.g.
thrombus or intramural hematoma) inner and
outer diameter including vessel wall thickness
should be reported.
iii) Aortic root measurements require ECG-gated
images. Diameter of the sinus portion should be
recorded as the maximum sinus to sinus meas-
urement perpendicular to the vessel centerline.
For more details and normal values refer to [82].
iv) Standardized structured reports with tables of
diameters are helpful for reporting follow-up
examinations.
b) Pulmonary artery:
i) Diameters are measured on double oblique
images perpendicular to the centerlines of the
pulmonary trunk as well as right and left
pulmonary arteries. It should be reported
whether the inner or outer contour was
measured. In oval shaped vessels the longest
diameter and its perpendicular diameter shall be
reported, with measurement during systole
recommended. Alternatively, cross-sectional area
may be measured. For normal values refer to [84].
c) Pulmonary veins:
i) Double oblique MPR of pulmonary veins
perpendicular to centerline for diameter
measurements. For a more comprehensive
assessment including flow measurements refer
to [85].
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